[HTML][HTML] Targeting glutamine metabolism as a therapeutic strategy for cancer

J Jin, JK Byun, YK Choi, KG Park - Experimental & Molecular Medicine, 2023 - nature.com
Proliferating cancer cells rely largely on glutamine for survival and proliferation. Glutamine
serves as a carbon source for the synthesis of lipids and metabolites via the TCA cycle, as …

Glutamine metabolism in breast cancer and possible therapeutic targets

S Li, H Zeng, J Fan, F Wang, C Xu, Y Li, J Tu… - Biochemical …, 2023 - Elsevier
Cancer is characterized by metabolic reprogramming, which is a hot topic in tumor treatment
research. Cancer cells alter metabolic pathways to promote their growth, and the common …

[HTML][HTML] Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance

HN Bell, RJ Rebernick, J Goyert, R Singhal, M Kuljanin… - Cancer cell, 2022 - cell.com
Microbial dysbiosis is a colorectal cancer (CRC) hallmark and contributes to inflammation,
tumor growth, and therapy response. Gut microbes signal via metabolites, but how the …

Colorectal cancer: Metabolic interactions reshape the tumor microenvironment

J Chen, H Zhu, Y Yin, S Jia, X Luo - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Colorectal cancer (CRC) is one of the most common cancers worldwide, which ranks third in
terms of incidence and the second leading cause of cancer-related mortality. Metabolic …

[HTML][HTML] Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review

L Zhang, W Zhang, Z Li, S Lin, T Zheng, B Hao… - Journal of Experimental …, 2022 - Springer
CD8+ T cells play a central role in anti-tumor immunity. Naïve CD8+ T cells are active upon
tumor antigen stimulation, and then differentiate into functional cells and migrate towards the …

[HTML][HTML] Breakthrough of solid tumor treatment: CAR-NK immunotherapy

W Wang, Y Liu, Z He, L Li, S Liu, M Jiang, B Zhao… - Cell Death …, 2024 - nature.com
As the latest and most anticipated method of tumor immunotherapy, CAR-NK therapy has
received increasing attention in recent years, and its safety and high efficiency have …

[HTML][HTML] Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells

KM Rattigan, Z Brabcova, D Sarnello, MM Zarou… - Nature …, 2023 - nature.com
Deregulated oxidative metabolism is a hallmark of leukaemia. While tyrosine kinase
inhibitors (TKIs) such as imatinib have increased survival of chronic myeloid leukaemia …

HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment

R Missiaen, NP Lesner, MC Simon - The EMBO journal, 2023 - embopress.org
A role for hypoxia‐inducible factors (HIFs) in hypoxia‐dependent regulation of tumor cell
metabolism has been thoroughly investigated and covered in reviews. However, there is …

[HTML][HTML] SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma

L Han, J Zhou, L Li, X Wu, Y Shi, W Cui, S Zhang… - Cell Death & …, 2022 - nature.com
Glioma is the most common type of primary malignant tumor in the central nervous system
with limited treatment satisfaction. Finding new therapeutic targets has remained a major …

Tryptophan and its metabolites in normal physiology and cancer etiology

L Perez‐Castro, R Garcia, N Venkateswaran… - The FEBS …, 2023 - Wiley Online Library
Within the growing field of amino acid metabolism, tryptophan (Trp) catabolism is an area of
increasing interest. Trp is essential for protein synthesis, and its metabolism gives rise to …